Xu J, Ling H, Geng J, Huang Y, et al. Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes mellitus: A 24-week, multi-center, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial. Diabetes Obes Metab 2022 Jul 6. doi: 10.1111/dom.14810.
PMID: 35791646